Investigation of the efficacy of rikkosan on oral pain

Investigation of the efficacy of rikkosan on oral pain - Investigation of the efficacy of rikkosan on oral pain

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012835

Enrollment

Registered

2014-01-13

Start date

2014-01-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with oral pain

Interventions

Oral administration of rikkosan (7.5g/day t.i.d.) with honey(15g/day t.i.d.) before meals for 3 days. Oral administration of honey(15g/day t.i.d.) before meals for 3 days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with oral pain

Exclusion criteria

Exclusion criteria: a) Patients being treated for following advanced conditions; atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, and other chronic disease b) Patients who are allergic to medicines, or foods related to the test material of this trial c) Pregnant women, lactating women, or women who want to get pregnant during the trial period d) Patients who are enrolled in the other clinical trials before the agreement for the participation to this trial e) Patients who are judged not suitable to participate in this trial by physician.

Design outcomes

Primary

Measure	Time frame
Pain index or pain score	—

Secondary

Measure	Time frame
Food intake	—

Countries

Japan

Contacts

Public ContactRyoko Kawahara

Nissay Hospital Anesthesiology and Palliative care

kawahara.ryoko@nissay-hp.or.jp06-6543-3581

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026